Detalhe da pesquisa
1.
Morbidity and mortality after major pulmonary resections in patients with locally advanced stage IIIA non-small cell lung carcinoma who underwent induction therapy.
Heart Lung Circ
; 24(1): 69-76, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25086910
2.
EGFR mutation testing practice in advanced non-small cell lung cancer.
Lung
; 192(5): 759-63, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24964874
3.
Major pulmonary resection after neoadjuvant chemotherapy or chemoradiation in potentially resectable stage III non-small cell lung carcinoma.
Sci Rep
; 11(1): 20232, 2021 10 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34642407
4.
Effectiveness and safety of nivolumab in advanced non-small cell lung cancer: The real-life data.
Lung Cancer
; 126: 217-223, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29254746
5.
Advanced non-small cell lung cancer: induction chemotherapy and chemoradiation before operation.
Ann Thorac Surg
; 74(2): 342-7, 2002 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-12173811
6.
Lobectomy for non-small cell lung cancer: differences in morbidity and mortality between thoracotomy and thoracoscopy.
Innovations (Phila)
; 7(1): 15-22, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22576031
7.
Symptom improvement in lung cancer patients treated with erlotinib: quality of life analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR.21.
J Clin Oncol
; 24(24): 3831-7, 2006 Aug 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-16921034